P L Iv Fund Purchaser Qualified Partners Venture Skyline

Affiliations

  • Large Shareholder at Proteon Therapeutics Inc (PRTO), 2014-10-29
  • Large Shareholder at Tetraphase Pharmaceuticals Inc (TTPH), 2014-03-14
  • Other at Acelrx Pharmaceuticals Inc (ACRX), 2014-03-12
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2014-02-21
  • Other at Arca Biopharma Inc. (ABIO), 2009-06-15
  • Large Shareholder at Targanta Therapeutics Corp. (TARG), 2009-02-27
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRTO $10.00 200,000 $2,000,000.00 200,000 2014-10-27 Filing
CNCE $14.00 150,000 $2,100,000.00 1,208,920 2014-02-20 Filing
TTPH $7.00 681,012 $4,767,084.00 2,190,145 2013-03-25 Filing
ACRX $3.40 284,698 $967,973.20 4,161,933 2012-05-29 Filing
ACRX $5.00 1,235,943 $6,179,715.00 3,877,235 2011-02-16 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PRTO $10.00 56,038 $560,380.00 1,432,930 2014-10-27 Filing
ABIO $3.90 6,100 $23,818.06 335,400 2009-06-15 Filing
ABIO $3.94 3,800 $14,989.86 341,500 2009-06-12 Filing
ABIO $3.84 40,700 $156,479.29 345,300 2009-06-11 Filing
ABIO $3.96 36,000 $142,448.40 386,000 2009-06-10 Filing